Jose T Aranez, MD
Obstetrics/Gynecology · Burbank
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 41 years
- Graduated 1985
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Aranez’s office at (818) 848-1420 to ask if they take your plan before you enroll.
California Medical Board record
Licence C51587 · Current
Licensed to practise in California · since 2004 · expires 2027-09-30 · University of the East, Ramon Magsaysay Memorial Medical Center.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$10,162
Medicare paid this office $10,162 for 42 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 23 | $3,792 | $69 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 21 | $892 | $42 |
Procedures Medicare counted
| Removal of the uterus | 1-10 | None |
Who their Medicare patients are
42 Original Medicare patients in 2024. Average age 66 · 85 and older 0% · Also on Medicaid 69% · Health risk score 0.86. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 75% · Depression 45% · Diabetes 40% · Coronary heart disease 31%.
The office billed $55,527, Medicare allowed $13,441 and paid $10,162; for 148 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 42 | 148 | 66 | 0.86 | $55,527 | $10,162 |
| 2023 | 47 | 159 | 67 | 1.26 | $42,562 | $12,750 |
| 2022 | 35 | 140 | 68 | 0.92 | $27,975 | $11,669 |
| 2021 | 25 | 73 | 64 | 0.73 | $14,870 | $5,852 |
| 2020 | 24 | 77 | 65 | 1.05 | $17,250 | $5,127 |
| 2019 | 40 | 103 | 67 | 1.52 | $21,345 | $7,182 |
| 2018 | 36 | 101 | 66 | 1.24 | $21,691 | $8,079 |
| 2017 | 23 | 66 | 60 | 0.98 | $11,835 | $4,614 |
| 2016 | 27 | 60 | 67 | 1.44 | $14,275 | $4,478 |
| 2015 | 26 | 59 | 67 | 0.90 | $16,675 | $5,682 |
| 2014 | 24 | 85 | 64 | 1.22 | $14,875 | $5,894 |
| 2013 | 13 | 31 | 63 | 0.74 | $10,710 | $2,502 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Short return visit (20+ min) | 25 | $4,079 | $70 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 29 | $1,243 | $43 |
2022: 2 services
| Short return visit (20+ min) | 23 | $4,343 | $75 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 26 | $1,131 | $44 |
2021: 2 services
| Short return visit (20+ min) | 17 | $2,840 | $73 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 14 | $614 | $44 |
2020: 1 service
| Short return visit (20+ min) | 15 | $2,554 | $62 |
2019: 3 services
| Short return visit (20+ min) | 17 | $2,028 | $63 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 17 | $829 | $49 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 17 | $727 | $43 |
2018: 3 services
| Short return visit (20+ min) | 17 | $2,038 | $62 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 18 | $872 | $48 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 17 | $691 | $41 |
2017: 3 services
| Short return visit (20+ min) | 13 | $1,401 | $61 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 12 | $589 | $49 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 12 | $497 | $41 |
2016: 2 services
| Short return visit (20+ min) | 12 | $1,239 | $62 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 11 | $450 | $41 |
2015: 1 service
| Short return visit (20+ min) | 14 | $1,366 | $62 |
2014: 3 services
| Short return visit (20+ min) | 12 | $1,873 | $60 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 14 | $685 | $49 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 13 | $531 | $41 |
Medicaid work
$225,424 in 2024
Medicaid paid $225,424 for 4,792 billed services this clinician did in 2024, up to 72 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 933 | $215,800 |
| Short return visit (20+ min) | 683 | $4,073 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 277 | $2,110 |
| New patient visit (30+ min) | 50 | $1,473 |
| Endometrial sampling (biopsy) with or without endocervical sampling (biopsy), without cervical dilation, any method (separate procedure) | 42 | $668 |
| Return visit (30+ min) | 55 | $549 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 41 | $331 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 13 | $150 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 49 | $150 |
| URINE PREGNANCY TEST | 123 | $90 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 124 | $30 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 144 | $0 |
| 2024 | 4,792 | 27 | 72 | $225,424 |
| 2023 | 2,204 | 16 | 59 | $41,801 |
| 2022 | 2,369 | 14 | 67 | $59,753 |
| 2021 | 2,349 | 16 | 67 | $87,328 |
| 2020 | 1,894 | 11 | 71 | $86,910 |
| 2019 | 1,686 | 10 | 66 | $76,482 |
| 2018 | 2,507 | 17 | 56 | $154,982 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 153 | $34,439 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 158 | $3,521 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 184 | $1,899 |
| Short return visit (20+ min) | 725 | $710 |
| New patient visit (45+ min) | 44 | $484 |
| New patient visit (30+ min) | 14 | $457 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 240 | $149 |
| Return visit (30+ min) | 96 | $96 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 39 | $38 |
| URINE PREGNANCY TEST | 133 | $8 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 76 | $0 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 181 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 221 | $49,786 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 169 | $4,867 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 73 | $3,475 |
| Short return visit (20+ min) | 799 | $958 |
| Return visit (30+ min) | 174 | $347 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 90 | $231 |
| Endometrial sampling (biopsy) with or without endocervical sampling (biopsy), without cervical dilation, any method (separate procedure) | 15 | $37 |
| Health behavior assessment | 41 | $33 |
| URINE PREGNANCY TEST | 113 | $20 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 181 | $0 |
| New patient visit (30+ min) | 13 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 57 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 371 | $84,231 |
| Short return visit (20+ min) | 710 | $1,479 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 45 | $782 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 20 | $248 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 15 | $221 |
| New patient visit (45+ min) | 12 | $201 |
| New patient visit (30+ min) | 41 | $141 |
| URINE PREGNANCY TEST | 142 | $23 |
| Endometrial sampling (biopsy) with or without endocervical sampling (biopsy), without cervical dilation, any method (separate procedure) | 25 | $0 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 254 | $0 |
| Culture, presumptive, pathogenic organisms, screening only | 12 | $0 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 15 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 369 | $82,924 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 109 | $2,559 |
| Short return visit (20+ min) | 697 | $630 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 13 | $354 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 229 | $292 |
| New patient visit (30+ min) | 52 | $152 |
| URINE PREGNANCY TEST | 77 | $0 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 19 | $0 |
| Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Public Health Emergency, as defined by law, due to respiratory-transmitted infectious disease | 24 | $0 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 125 | $0 |
| Service | 180 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 250 | $53,762 |
| OBSTETRICAL CARE | 27 | $13,536 |
| Cesarean delivery | 43 | $7,331 |
| New patient visit (30+ min) | 212 | $1,325 |
| Short return visit (20+ min) | 663 | $500 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 85 | $26 |
| URINE PREGNANCY TEST | 132 | $3 |
| Endometrial sampling (biopsy) with or without endocervical sampling (biopsy), without cervical dilation, any method (separate procedure) | 38 | $0 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 84 | $0 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 152 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 620 | $129,285 |
| Cesarean delivery | 59 | $8,836 |
| OBSTETRICAL CARE | 25 | $6,749 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 75 | $2,113 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 75 | $2,106 |
| OBSTETRIC PANEL | 58 | $1,871 |
| New patient visit (30+ min) | 91 | $1,675 |
| Short return visit (20+ min) | 603 | $1,346 |
| Antibody; HIV-1 | 66 | $472 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 59 | $358 |
| Blood glucose (sugar) level | 57 | $169 |
| URINE PREGNANCY TEST | 44 | $3 |
Drugs they prescribed that Part D paid
$10,547
Pharmacies billed $10,547 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
129 generic and fewer than 11 brand-name prescriptions · $10,547 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol | 15 | $3,972 | $88 |
Year by year
| 2024 | 142 | 47 | None | None | $10,547 |
| 2023 | 119 | 46 | 0% (0) | None | $9,075 |
| 2022 | 54 | 18 | 0% (0) | None | $3,438 |
| 2021 | 66 | 23 | 0% (0) | 23% | $8,527 |
| 2020 | 98 | 32 | None | 29% | $9,024 |
| 2019 | 92 | 29 | 0% (0) | 40% | $12,892 |
| 2018 | 91 | 34 | None | 23% | $11,690 |
| 2017 | 99 | 26 | 0% (0) | 28% | $8,690 |
| 2016 | 63 | 28 | None | 17% | $4,371 |
| 2015 | 93 | 33 | 0% (0) | 28% | $7,818 |
| 2014 | 103 | 39 | None | 20% | $5,896 |
| 2013 | 178 | 40 | None | None | $11,214 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Estradiol | 31 | $3,555 | $115 |
| Yuvafem | 21 | $2,142 | $102 |
| Fyavolv | 13 | $696 | $54 |
| Clotrimazole-Betamethasone | 15 | $221 | $15 |
2022: 1 drug
| Fyavolv | 12 | $893 | $74 |
2021: 1 drug
| Fyavolv | 11 | $746 | $68 |
2020: 3 drugs
| Prempro | 14 | $3,258 | $233 |
| Clobetasol Propionate | 14 | $1,182 | $84 |
| Larin Fe | 11 | $118 | $11 |
2019: 2 drugs
| Prempro | 23 | $5,516 | $240 |
| Clobetasol Propionate | 11 | $1,986 | $181 |
2018: 1 drug
| Estradiol | 13 | $3,435 | $264 |
2017: 3 drugs
| Prempro | 13 | $2,579 | $198 |
| Cryselle | 14 | $247 | $18 |
| Metformin | 14 | $35 | $2 |
2016: 1 drug
| Metformin | 12 | $50 | $4 |
2015: 2 drugs
| Metformin | 12 | $49 | $4 |
| Ibuprofen | 11 | $32 | $3 |
2014: 1 drug
| Metformin | 12 | $68 | $6 |
2013: 2 drugs
| Clobetasol Propionate | 20 | $487 | $24 |
| Metformin | 12 | $71 | $6 |
Money from drug and device companies
$3,735 in 2025
| 2025 | 7 | 16 | $3,600 | $3,735 |
| 2024 | 5 | 12 | $3,400 | $3,516 |
| 2023 | 3 | 5 | None | $243 |
| 2022 | 3 | 19 | None | $724 |
| 2021 | 3 | 40 | None | $866 |
| 2020 | 4 | 20 | None | $578 |
| 2019 | 5 | 31 | None | $1,394 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| MIMEDX Group | Bovine Collagen | $3,600 | 9 payments
|
| CooperSurgical | Paragard T 380a | $40 | 2 payments
|
| Pfizer | Velsipity | $28 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $25 | 1 payment
|
| Millicent US | Femlyv | $19 | 1 payment
|
| Hologic Sales and Service | Thinprep 2000 Processor | $16 | 1 payment
|
See all 16 published payments
| Pfizer | Meals · 2025-12-23 | Velsipity | $28 |
| MIMEDX Group | Consulting · 2025-11-03 | None | $200 |
| Millicent US | Meals · 2025-10-08 | Femlyv | $19 |
| MIMEDX Group | Consulting · 2025-10-01 | None | $1,000 |
| CooperSurgical | Meals · 2025-09-24 | Paragard T 380a | $18 |
| MIMEDX Group | Consulting · 2025-09-03 | None | $200 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-08-11 | Xifaxan | $25 |
| MIMEDX Group | Consulting · 2025-08-04 | None | $200 |
| Hologic Sales and Service | Meals · 2025-06-09 | Thinprep 2000 Processor | $16 |
| MIMEDX Group | Consulting · 2025-06-02 | None | $600 |
| Mayne Pharma Commercial | Meals · 2025-05-06 | None | $7 |
| MIMEDX Group | Consulting · 2025-05-01 | None | $600 |
| MIMEDX Group | Consulting · 2025-04-02 | None | $200 |
| CooperSurgical | Meals · 2025-04-02 | Paragard T 380a | $22 |
| MIMEDX Group | Consulting · 2025-02-04 | Bovine Collagen | $200 |
| MIMEDX Group | Consulting · 2025-01-03 | Bovine Collagen | $400 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $3,516
| MIMEDX Group | None | $3,400 | 7 payments
|
| Astellas Pharma US | Veozah | $47 | 2 payments
|
| Sage Therapeutics | Zurzuvae | $24 | 1 payment
|
| Medicem | Dilapan-S | $23 | 1 payment
|
| Boston Scientific | Exalt Model D | $22 | 1 payment
|
2023: $243
| Boston Scientific | Exalt Model D | $190 | 3 payments
|
| AbbVie | Lo Loestrin Fe | $30 | 1 payment
|
| Mayne Pharma Commercial | None | $23 | 1 payment
|
2022: $724
| Boston Scientific | Exalt Model D | $597 | 16 payments
|
| Coloplast | Restorelle | $71 | 1 payment
|
| Abbvie | Lo Loestrin Fe | $56 | 2 payments
|
2021: $866
| Boston Scientific | Exalt | $552 | 24 payments
|
| AbbVie | Orilissa | $271 | 14 payments
|
| TherapeuticsMD | Annovera | $43 | 2 payments
|
2020: $578
| AbbVie | Orilissa | $243 | 11 payments
|
| TherapeuticsMD | Annovera | $172 | 5 payments
|
| Boston Scientific | Spyglass | $145 | 3 payments
|
| Merck Sharp & Dohme | Nexplanon | $19 | 1 payment
|
2019: $1,394
| AbbVie | Orilissa | $998 | 21 payments
|
| AMAG Pharmaceuticals | Intrarosa | $321 | 6 payments
|
| TherapeuticsMD | Bijuva | $33 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Mirena | $23 | 1 payment
|
| Hologic | Thinprep | $18 | 1 payment
|
Professional record
- NPI
- 1740255330
- Licence
- CA C51587California C51587: Current · expires 2027-09-30
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- OH 0236248, OH 2131268
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 2701 W Alameda Ave, Suite 407, Burbank, CA, 91505
- NPI first listed
- 2006-02-17
- NPI last updated
- 2018-07-09
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 5820 N Figueroa St, Los Angeles, CA, 90042